AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Lymphoma

A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Ensartinib Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL NCT07234487Phase 23 sites๐Ÿ“ Moscow๐Ÿ“ Moscow๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Nivo-AVD, BEACOPP-like A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor NCT06615193Phase 18 sites๐Ÿ“ Zhengzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ยท Tests: HDM2005 Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors NCT05156203Phase 13 sites๐Ÿ“ Kaohsiung City๐Ÿ“ Taipei๐Ÿ“ Taoyuan City Taivex Therapeutics Corporation ยท Tests: T-1301 Capsules Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma NCT06583083Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Sintilimab with P-GEMOX Regimen, P-GEMOX Regimen A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles AVM Biotechnology Inc ยท Tests: AVM0703 Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer NCT07215910Phase 3152 sites๐Ÿ“ Bakersfield๐Ÿ“ Duarte๐Ÿ“ Dublin Alliance for Clinical Trials in Oncology ยท Tests: Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Tโ€ฆ A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer NCT05659732Phase 15 sites๐Ÿ“ Clayton๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung PharmaEngine ยท Tests: PEP07 Study of AXT-1003 in Subjects With Advanced Malignant Tumors. NCT06484985Phase 15 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Fuzhou Axter Therapeutics (Beijing) Co., Ltd ยท Tests: AXT-1003 Nivo40-AVD for Advanced Classic Hodgkin Lymphoma NCT06984146Phase 21 site๐Ÿ“ Moscow National Medical Research Radiological Centre of the Ministโ€ฆ ยท Tests: Nivolumab, Doxorubicin, Vinblastine, Dacarbazine Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma NCT05949931Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Concurrent penpulimab and AVD, Sequential penpulimab and AVD Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Haihe Biopharma Co., Ltd. ยท Tests: HH2853 Tablets The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease NCT06795815NA1 site๐Ÿ“ Reggio Emilia Azienda USL Reggio Emilia - IRCCS ยท Tests: Go Wish Game First in Human, Dose Escalation Study of AN4005 NCT04999384Phase 17 sites๐Ÿ“ Hackensack๐Ÿ“ The Bronx๐Ÿ“ Greenville Adlai Nortye Biopharma Co., Ltd. ยท Tests: AN4005-dose level 0, AN4005-dose level 1, AN4005-dose level 2, AN4005-dose level 3, AN4005-dose level 4 A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors NCT06292208Phase 1, Phase 21 site๐Ÿ“ Jinan SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd. ยท Tests: IBD0333 Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib NCT06620835Phase 227 sites๐Ÿ“ Brest๐Ÿ“ Caen๐Ÿ“ Chambรฉry Groupe Francais De Pneumo-Cancerologie ยท Tests: Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests, Pregnancy test, Tumouโ€ฆ Intratumoral CAN2109 in Subjects With Solid Tumors NCT06332430Phase 11 site๐Ÿ“ Guangzhou Canwell Biotech Limited ยท Tests: CAN2109 A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma NCT05341557Phase 14 sites๐Ÿ“ Chaoyang๐Ÿ“ Cangzhou๐Ÿ“ Tianjin Betta Pharmaceuticals Co., Ltd. ยท Tests: BPI-371153 Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site๐Ÿ“ Hangzhou Zhejiang Provincial People's Hospital ยท Tests: Mirabegron Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) NCT03297606Phase 210 sites๐Ÿ“ Edmonton๐Ÿ“ Kelowna๐Ÿ“ Vancouver Canadian Cancer Trials Group ยท Tests: Olaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD146/HER2 CAR-T cells Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 Combination of CAR-DC Vaccine and ICIs in Malignant Tumors NCT05631886Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide, anti-PD-1 antibody, Anti-CTLA4 Monoclonal Antibody Swedish Cardiac And Renal Failure Study-1 NCT07029503Phase 21 site๐Ÿ“ Stockholm Karolinska Institutet ยท Tests: Eplerenone IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas NCT05365659Phase 113 sites๐Ÿ“ Baltimore๐Ÿ“ Westmead๐Ÿ“ Adelaide Iksuda Therapeutics Ltd. ยท Tests: IKS03 A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Enzalutamide Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naรฏve Advanced Stage Follicular Lymphoma NCT07126678NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: zanubrutinib, bendamustine, and obinutuzumab PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma NCT07209059Phase 21 site๐Ÿ“ Moscow National Research Center for Hematology, Russia ยท Tests: Nivolumab, N-EACOPD-14, N-AVD
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy